RESUMO
Micro-credentials (MCs) and digital badges (DBs) have gained popularity in recent years as a means to supplement traditional degrees and certifications. MCs and DBs can play a significant role in supporting student-centered learning by offering personalized and flexible learning pathways, emphasizing real-world relevance and practical skills, and fostering a culture of continuous learning and growth. However, barriers currently exist within health professions education, including pharmacy education, that could limit the full adoption and implementation of MCs and DBs. Research on the use of MCs and DBs in Doctor of Pharmacy degree programs is sparse. In this integrative review, literature on the use of MCs and DBs in health professions education is reviewed, and perspectives on the benefits, issues, and potential future uses within Doctor of Pharmacy degree programs are presented.
Assuntos
Educação em Farmácia , Assistência Farmacêutica , Farmácia , Humanos , Aprendizagem , CurrículoRESUMO
Purpose: To assess pharmacists' mental well-being, perceptions of safety, and willingness to administer vaccines before and during the COVID-19 pandemic. Methods: An electronic survey was administered to a convenient sample of practicing pharmacists working in Alabama, Tennessee and Texas. The 33-item survey examined pharmacists' beliefs about the pandemic's impact on their mental well-being, their perceptions of safety in vaccine administration, and their willingness to vaccinate. Responses were assessed on a 5-point Likert scale, ranging from strongly disagree (1) to strongly agree (5). A recruitment email with the survey link was sent to pharmacists, with periodic reminders over a 4-week period. Descriptive statistics and bivariate analyses were utilized to evaluate survey responses. Results: A total of 387 responses were analyzed, with an estimated response rate of 3.93%. Most respondents were women (65%) and had at least 6 to 10 years of practice experience (28%). Overall, participants felt that the pandemic worsened their mental well-being, with women reporting a more negative mental well-being compared with men (P < .001). They reported having less time during workflow to apply personal protective equipment (PPE) (P = .0074) compared to before the pandemic. They also reported a decrease in willingness to vaccinate adult patients during the pandemic (P < .0001), and that concern about contracting COVID-19 prevented them from giving vaccinations (P < .0001). Conclusions: Pharmacists felt their mental well-being and willingness to vaccinate patients suffered as a result of the COVID-19 pandemic. Future research and initiatives that focus on improving vaccination rates should also consider pharmacists' concerns and well-being.
RESUMO
OBJECTIVE: To determine how implementing a systematic medication therapy management (MTM) process impacted MTM completion rates. METHODS: This process improvement pilot included 4 grocery store-based community pharmacy sites. Site staff were trained on a systematic process to integrate OutcomesMTM opportunities into pharmacy workflow. Technicians prepared MTM paperwork, including a standardized comprehensive medication review (CMR) worksheet, which pharmacists used to deliver the service at the counsel window. The primary outcome was the change in CMR completion rate from pre- to post implementation, with each site serving as its own control. Secondary outcomes were change in targeted intervention program (TIP) completion rate and survey results assessing barriers and feasibility. RESULTS: The mean CMR completion rate improved from 2.7% ± 5.4% to 23.2% ± 7.7% (P < .10). The mean TIP completion rate improved from 3.4% ± 4.2% to 24.9% ± 19.2% (P < 0.10) pre- to post-implementation. Survey results indicated that pharmacists were satisfied with this; the most significant barriers were time spent contacting prescribers, documentation, and claim submission. CONCLUSION: Implementing this systematic approach to providing MTM into the pharmacy workflow may lead to an improvement in CMR completion rate. However, the sample size is small, and the results and process may not be generalizable to other sites.
Assuntos
Serviços Comunitários de Farmácia/organização & administração , Conduta do Tratamento Medicamentoso/organização & administração , Estudos de Viabilidade , Humanos , Farmacêuticos/psicologia , Projetos PilotoRESUMO
The stockpiling and improper disposal of unused or expired medications has the potential to harm the environment and humans. Community-based medication take-back programs have been established to ensure proper disposal of unused drugs; however, few of these programs present consumers' perceptions about the program. Therefore, the main aims of this pilot study are 1) to assess the users' and non-users' perceptions about a medication take-back program and 2) to determine if perceptions differ between users and non-users. The results are based on a survey administered to 35 users and 20 non-users of a medication take-back program located at a community pharmacy in Texas. The majority of users were participating in a take-back service for the first time. Though most non-users had never participated in a take-back program, they would consider participating in the future. All users viewed the medication take-back program as a valuable service, while nearly all (90%) non-users viewed the program as a potentially valuable service. The primary reason for participating in the service was to protect the environment. Most respondents (users and non-users) were likely to choose a pharmacy that provides the take-back service more than a pharmacy that does not. More than half of respondents positively viewed paying for the service on a per weight basis. In comparison to non-users, users were significantly older, had more favorable perceptions about paying for the service, and were more likely to choose a pharmacy that provides the service. This pilot study presents overall favorable user perceptions toward medication-take back services and supports the need to establish more community-based take back programs to meet the needs of consumers.
Assuntos
Preparações Farmacêuticas , Farmácias , Gerenciamento de Resíduos , Participação da Comunidade/psicologia , Feminino , Humanos , Masculino , Projetos Piloto , Responsabilidade Social , Fatores Socioeconômicos , TexasRESUMO
PURPOSE: The purpose of this study was to assess (1) medication adherence in individuals with diabetes, (2) barriers to adherence, and (3) what factors were related to medication nonadherence. METHODS: A self-administered anonymous survey was provided to adults with diabetes (N = 59) who used a grocery store chain pharmacy or a community clinic for the underserved. Participants were recruited by pharmacy staff to complete a 10- to 15-minute survey to assess adherence, access, barriers, medication use, and demographics. Adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS), which is a reliable and valid self-report adherence instrument. Access (e.g., use medications from Mexico, transportation), barriers (e.g., cost, language difficulties), medication use (e.g., complementary and alternative medicine, prescription medication), and demographics were also measured. The survey was available in English and Spanish. Data collection occurred from December 2010 through February 2011. RESULTS: Fifty-nine participants completed the survey. Approximately 57% of study participants were male, 85% were Hispanic, and the mean age was 50.4 ± 10.3 years. Over 50% of participants had hypertension or dyslipidemia and were taking 3 or more medications. Participants (52.6%) reported their health status as good or excellent and over one-half (56%) of the participants were nonadherent (score 0-6). The following factors were significantly (P < .05) related to nonadherence: cost, no refills, poor health status, fewer disease states, and any reason. CONCLUSIONS: This study increased awareness of barriers to medication adherence in a predominantly Hispanic underserved patient population. This may lead to more informed recommendations and perhaps address gaps in health disparities.